When we look at some of the key sources of whats driving that, its hard for me to create a story where those dynamics will go away and trends will come down, Guerriere said
Ooi E et al
This is psychological, not a sign the medication has permanently stopped working
What outcomes (QALY, life-years gained, etc.) and which costs (NHS only vs broader) are considered
A recent small clinical trial employing the GLP-1R agonist Exenatide, which has the same amino acid sequence as Ex4, demonstrated promising early results (ICP reductions of 13 mmHg) in IIH patients [27]
Cellular energy, mitochondrial function and fatigue NAD+ is the coenzyme that mitochondria the energy factories of every cell depend on to convert food into ATP, the molecular currency of energy